Clinical Trials
8 trialsNCT00365105 2024-09-20
Zoledronate, Vitamin D, and Calcium With or Without Strontium 89 or Samarium 153 in Preventing or Delaying Bone Problems in Patients With Bone Metastases From Prostate Cancer, Lung Cancer, or Breast Cancer
Radiation Therapy Oncology Group
Phase 3 Completed
NCT00265200 2018-03-05
Using TRAP to Evaluate the Effect of Zometa on Bone Metastasis Due to Lung Cancer
University of Louisville
Phase 2 Terminated
NCT00086268 2017-09-13
ZPACT
Novartis
Phase 3 Completed
NCT02622607 2017-07-21
Preventive Effects of Zoledronic Acid on Bone Metastasis in Patients With Stage IIIB and IV Lung Cancer
Tang-Du Hospital
Phase 3 Unknown
NCT00003884 2013-02-21
Zoledronate in Treating Patients With Solid Tumors That Have Spread to the Bone
Novartis
Phase 3 Completed
NCT01737216 2012-12-31
Pilot Study of Zoledronic Acid in Combination With First-line Chemotherapy in Aged Patients With Lung Cancer
Hebei Tumor Hospital
Phase 2 Unknown
NCT00264420 2010-12-21
Safety and Efficacy Study of Concomitant Radiotherapy and Zoledronic Acid for Bone Metastases Palliation
The Cleveland Clinic
Phase 1 Completed
NCT00099541 2009-11-23
Non-small Cell Lung Cancer Registry
Novartis
Phase 4 Completed